Acadia Pharma 2023 Earnings Preview
by
Contributor since / Followers
Contributor since / Followers
10 months ago
- Acadia Pharma (NASDAQ:ACAD) is scheduled to announce earnings results on Tuesday, February 27th, after market close.
- The consensus EPS Estimate is $0.31 and the consensus Revenue Estimate is $223.8M.
- Over the last 3 months, EPS estimates have seen 3 upward revisions and 3 downward. Revenue estimates have seen 6 upward revisions and 2 downward.